Skip to content

Investigation Into the Microorganisms in Pregnant Women

Investigation Into the Fungal Microbiome (Mycobiome) in the Cervices of Cervical Insufficiency Patients Receiving Cerclage Treatment and Resulting in Term or Preterm Birth

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04688866
Enrollment
200
Registered
2020-12-30
Start date
2012-06-05
Completion date
2025-12-31
Last updated
2023-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Insufficiency, Preterm Birth

Keywords

preterm birth, cervical insufficiency, cerclage, pessary

Brief summary

Pregnant women with short cervical length (\<25 mm) in second-trimester ultrasonographic assessment are at high risk for preterm birth, a major cause of perinatal mortality and morbidity worldwide. Some of these short-cervix women proceed to a more advanced stage manifested as a painless prematurely dilated cervix in the second trimester. It is not fully understood why some women have short cervical length or prematurely dilated cervix (cervical insufficiency), although evidence is mounting that there is an association between short cervical length and infection by microorganisms. The investigators hypothesize that the cervical microorganisms in pregnant women with a shortened or dilated cervix are different, compared with those in women with normal cervical length and a closed cervix.

Detailed description

Previously, culture-dependent methods were used to detect bacterial or fungal infection, but the sensitivity was low, since not all species grew well in culture. Recently, molecular methods based on PCR amplification of the bacterial 16S ribosomal RNA (rRNA) gene or the fungal internal transcribed spacer (ITS) followed by capillary sequencing has been used to identify bacteria and fungi. However, the resolution of such capillary sequencing-based method (\<100 sequencing reads/sample) is too low to capture the major collection of microorganisms in a sample. Less abundant but possibly pathogenic microorganisms associated with short cervical length remain undetectable. To address the current gap in this field, we propose to more comprehensively survey microbial communities in the cervix of pregnant women by PCR amplification of the 16S rRNA region, ITS or other genomic regions with taxonomic classification potential. This will be followed by next-generation sequencing (\>40,000 sequencing reads/sample), which has been proven to capture the majority of microorganisms in a sample.

Interventions

OTHERSequencing

This is an observational study, since the assignment of the medical intervention (e.g. cerclage or pessary) is not at the discretion of the investigator. However, cervical samples collected from both groups are subjected to amplicon sequencing for taxonomic classification of microorganisms.

Sponsors

Hallym University
CollaboratorOTHER
Health and Medical Research Fund
CollaboratorOTHER_GOV
Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Women with or without cervical insufficiency (cervical length \<25 mm or dilated cervix in the second trimester or the late first trimester)

Exclusion criteria

* multiple pregnancies and pregnancies associated with fetal chromosomal abnormality

Design outcomes

Primary

MeasureTime frameDescription
Abundances of microorganisms in the cervix1 yearAbundances of microorganisms including bacteria and fungi in the cervix are measured by normalized sequencing read counts

Secondary

MeasureTime frame
Gestational age at delivery1 year
Mode of delivery1 year
Number of participants who received cerclage or ring pessary in the current pregnancy1 year

Countries

Hong Kong

Contacts

Primary ContactStephen S Chim, PhD
sschim@cuhk.edu.hk(852)35051324
Backup ContactKaren K Wong, MPhil
wkwkaren@cuhk.edu.hk(852)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026